Stock falls 6.2% following announcement
- iBio shares sink 6.2% after 20-to-1 reverse stock split
- Stock down to 27 cents in after-hours trading
- Shares expected to begin trading on a split-adjusted basis on Nov. 29
Shares of iBio took a hit after the company revealed a 20-to-1 reverse stock split. The stock dropped 6.2% to 27 cents in after-hours trading, following a 3.7% increase at Monday’s close. This year, shares have declined by 35%. The biopharmaceutical company stated that the reverse split was approved by stockholders during the annual meeting. Trading on a split-adjusted basis is expected to commence on November 29 when the market opens.
Factuality Level: 8
Factuality Justification: The article provides factual information about iBio’s stock falling after announcing a reverse stock split. It also mentions the percentage decrease in stock price and the date when the split-adjusted trading is expected to begin. The information is concise and does not contain any irrelevant or misleading details. However, the article lacks additional context or analysis, which could have provided a more comprehensive understanding of the situation.
Noise Level: 3
Noise Justification: The article provides relevant information about iBio’s stock falling after a reverse stock split. It includes details about the stock’s performance, the reason for the reverse split, and the expected trading date. However, it lacks in-depth analysis, scientific rigor, and actionable insights. The article stays on topic and supports its claims with facts and data, but it does not explore long-term trends or consequences for stakeholders.
Financial Relevance: Yes
Financial Markets Impacted: Stock market
Presence Of Extreme Event: No
Nature Of Extreme Event: No
Impact Rating Of The Extreme Event: No
Rating Justification: The news article pertains to a financial event, specifically a reverse stock split announced by iBio. This event may impact the company’s stock price and potentially the stock market as a whole.
Public Companies: iBio (IBIO)
Key People:
Reported publicly:
www.marketwatch.com 
